Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.40 |
| ▸ | ALOX5 | P09917 | 4/20 | 0.38 |
| ▸ | TYR | P14679 | 2/20 | 0.38 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.35 |
| ▸ | ACR | P10323 | 1/20 | 0.35 |
| ▸ | CNR2 | P34972 | 4/20 | 0.33 |
| ▸ | CNR1 | P21554 | 3/20 | 0.33 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.33 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5679086 | 1.00 | CYP3A4 (0.40) | CYP3A4CYP2D6CYP2C9ALOX5TYR | |
| SCHEMBL5679089 | 1.00 | CYP3A4 (0.40) | CYP3A4CYP2D6CYP2C9ALOX5TYR | |
| SCHEMBL5676860 | 1.00 | CYP3A4 (0.40) | CYP3A4CYP2D6CYP2C9ALOX5TYR | |
| SCHEMBL5921054 | 1.00 | CYP3A4 (0.40) | CYP3A4CYP2D6CYP2C9ALOX5TYR | |
| SCHEMBL5921050 | 1.00 | CYP3A4 (0.40) | CYP3A4CYP2D6CYP2C9ALOX5TYR | |
| SCHEMBL5676867 | 1.00 | CYP3A4 (0.40) | CYP3A4CYP2D6CYP2C9ALOX5TYR | |
| SCHEMBL5920160 | 1.00 | CYP3A4 (0.40) | CYP3A4CYP2D6CYP2C9ALOX5TYR | |
| SCHEMBL5920179 | 0.99 | CYP3A4 (0.38) | CYP3A4CYP2D6CYP2C9ALOX5TYR | |
| SCHEMBL5920185 | 0.99 | CYP3A4 (0.38) | CYP3A4CYP2D6CYP2C9ALOX5TYR | |
| SCHEMBL5680626 | 0.97 | CYP3A4 (0.40) | CYP3A4CYP2D6CYP2C9ALOX5TYR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060036049-A1 | Soluble late transition metal catalysts for olefin oligomerizations III | ZHAO BAIYI | 2006-02-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060036049-A1 | Soluble late transition metal catalysts for olefin oligomerizations III | COMT, CD69, SPR | CYP3A4 1091/4885CYP2D6 2875/4885CYP2C9 3740/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.